Nirmatrelvir/Ritonavir in Breast Milk: Low Infant Exposure in Lactating Women
Paxlovid levels low in breast milk, early study finds
This Phase 1 open-label study in 8 healthy lactating women found that nirmatrelvir/ritonavir concentrations in breast milk were consistently…
A small study finds that nirmatrelvir/ritonavir (Paxlovid) passes into breast milk at low levels, suggesting minimal infant exposure.
Nirmatrelvir-ritonavir showed no reduction in hospitalization or death within 28 days for higher-risk adults in community trials
New Study Questions Early Use of Paxlovid for Vaccinated Patients
In community-based trials involving higher-risk adults with recent SARS-CoV-2 infection, adding nirmatrelvir-ritonavir to usual care did not…
Getting vaccinated changes how your body fights the virus, and this new research shows that taking Paxlovid early might not be necessary for…
Nirmatrelvir-ritonavir reduced viral production by approximately 55% in SARS-CoV-2 BA.2-infected patients in Shanghai
Your COVID Pill May Work Better—Or Worse—Than You Think
This cohort study of 48,243 SARS-CoV-2 BA.2-infected patients in Shanghai evaluated nirmatrelvir-ritonavir exposure.
How well your Paxlovid works depends heavily on your age and vaccination status.
Paxlovid prescription associated with 51% lower hospitalization risk in US adults with COVID-19
Paxlovid prescription linked to lower hospitalization risk in adults with COVID-19
An observational study of eligible US adults with COVID-19 found those prescribed Paxlovid were 51% less likely to be hospitalized.
Adults prescribed Paxlovid for COVID-19 were 51% less likely to be hospitalized compared to those who did not get the medication.
Clinical trials examine COVID-19 rebound after nirmatrelvir/ritonavir versus placebo treatment
Does the COVID-19 rebound risk change with or without Paxlovid treatment?
Randomized, double-blind trials at U.S. and international sites investigated COVID-19 rebound following nirmatrelvir/ritonavir treatment ver…
Two rigorous clinical trials are investigating whether Paxlovid treatment changes the risk of COVID-19 symptoms returning after patients sta…
Observational study finds low hospitalization and ED visit rates after Paxlovid treatment for COVID-19 in California
Did Paxlovid keep COVID patients in California out of the hospital?
An observational study of patients in California treated with Paxlovid for COVID-19 reported low rates of subsequent hospitalizations and em…
Paxlovid treatment for COVID-19 in California was linked to low rates of hospitalizations and emergency department visits, offering hope for…